Literature DB >> 33039720

The protective effect of 5-O-methylvisammioside on LPS-induced depression in mice by inhibiting the over activation of BV-2 microglia through Nf-κB/IκB-α pathway.

Xialin Sun1, Tingwen Zhang1, Yan Zhao2, Enbo Cai1, Hongyan Zhu1, Shuangli Liu3.   

Abstract

BACKGROUND: 5-O-methylvisammioside (MeV), also known as 4'-O-β-D-glucosyl-5-O-methylvisamminol, is a conventional marker compound for quality control of roots of Saposhnikovia diviaricata (Radix Saposhnikoviae), which exhibits anti-inflammatory and neuroprotective activities.
PURPOSE: According to the activity of MeV, we speculated that MeV may have antidepressant effect on LPS induced depression, and further explored its mechanism. STUDY
DESIGN: First, to explore the effect and mechanism of MeV on LPS-induced depression in mice, and then to further explore the effect and mechanism of MeV on LPS-activated BV-2 microglia.
METHODS: By the OFT, EPM, TST and FST behavioral tests, to explore the effect of MeV pretreatment on the behavior of LPS-induced depression mice. ELISA and Griess method were used to detect the changes of the serum TNF-α and IL-6 levels, the hippocampus SOD and MDA levels, and the NO, SOD, MDA, TNF-α and IL-6 levels in the culture medium of LPS-stimulated BV-2 microglia. Western blot was used to analyze the protein expression in the Nf-κB/IκB-α and BDNF/TrkB pathway in the hippocampus of mice and BV-2 microglia.
RESULTS: MeV (4 mg/kg, i.p.) pretreatment significantly improves the activity and exploration ability of LPS-induced depression mice, and reduces the immobility time. MeV inhibited the production of pro-inflammatory cytokines in the serum of mice induced by LPS, such as IL-6 and TNF-α. MeV also increased the levels of SOD and reduces the expression of MDA in the hippocampus, thus promoting the alleviation of depressive symptoms in mice. Western blotting analysis showed that the antidepressant activity of MeV was related to the decrease of Nf-κB nuclear transport, the inhibition of IκB-α phosphorylation, and the increase of BDNF and TrkB expression. MeV (40 μM) significantly reduced the contents of NO, MDA, TNF-α and IL-6 in the culture medium of LPS-stimulated BV-2 microglia, and increased the content of SOD.
CONCLUSION: MeV can regulate the neurotrophic factors in the mouse brain, reduce the content of inflammatory factors by the Nf-κB/IκB-α pathway, improve oxidative stress, and inhibit the excessive activation of LPS-stimulated BV -2 microglia. It effectively reversed the depression-like behAavior induced by LPS in mice.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  5-O-methylvisammioside; BDNF; BV-2 microglia; Behavioral research; LPS-induced depression; Nf-κB

Mesh:

Substances:

Year:  2020        PMID: 33039720     DOI: 10.1016/j.phymed.2020.153348

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

Review 1.  Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression.

Authors:  Haixia Wang; Yi He; Zuoli Sun; Siyu Ren; Mingxia Liu; Gang Wang; Jian Yang
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

2.  Emodin Promotes Autophagy and Prevents Apoptosis in Sepsis-Associated Encephalopathy through Activating BDNF/TrkB Signaling.

Authors:  Li-Li Gao; Zhi-Hao Wang; Yu-Hang Mu; Zuo-Long Liu; Li Pang
Journal:  Pathobiology       Date:  2021-12-06       Impact factor: 3.916

3.  Anti-inflammatory activity of cyanidin-3-O-glucoside and cyanidin-3-O-glucoside liposomes in THP-1 macrophages.

Authors:  Xuefang Hao; Rongfa Guan; Haizhi Huang; Kai Yang; Lina Wang; Yuanfeng Wu
Journal:  Food Sci Nutr       Date:  2021-10-29       Impact factor: 2.863

4.  Botanical Drug Puerarin Ameliorates Liposaccharide-Induced Depressive Behaviors in Mice via Inhibiting RagA/mTOR/p70S6K Pathways.

Authors:  Jia Zhao; Yizhen Jia; Wei Zhao; Huixin Chen; Xiuying Zhang; Fung Yin Ngo; Dan Luo; Youqiang Song; Lixing Lao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.